United States Biotechnology & Medical Research

Humacyte Inc (HUMA)

Track

Over the past 90 days, Humacyte Inc. recorded 8 insider transactions, resulting in a net value of approximately $59,839. While recent activity includes both buy orders and planned sales by officers, the company's stock has declined 17.8% over the same period. These transactions follow the company's May 2026 earnings report, which showed an earnings per share beat.
Ticker: HUMA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Humacyte Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 19 May 2026
Value US$2,910,375.11 | Price 46.06 | Shares 85,795 (+17.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-20 2026-05-19 B Purchase
3.1
Sebelius Kathleen
Non-Executive Director
85,795 +17.4%
46.06
US$2,910,375 		85,795 +17.4% 46.06 US$2,910,375
2026-05-20 2026-05-18 PlS Planned sale
2.4
Parikh Shamik J

Chief Medical Officer

Officer
96,856 +29.2%
201.40
US$2,772,386 		96,856 +29.2% 201.40 US$2,772,386
2026-05-20 2026-05-18 PlS Planned sale
3.4
Sander Dale A.

CFO and Chief Corp. Dev. Off

Officer
52,283 -9.7%
376.51
US$2,500,861 		52,283 -9.7% 376.51 US$2,500,861
2026-05-20 2026-05-18 B Purchase
2.3
Constantino Michael T.
Non-Executive Director
11,000 +33.4%
0.89
US$9,840 		11,000 +33.4% 0.89 US$9,840
2026-05-18 2026-05-18 PrS Proposed sale
2.4
Parikh Shamik J

Officer

Officer
45,887
0.90
US$41,147 		45,887 0.90 US$41,147
2026-05-18 2026-05-18 PrS Proposed sale
2.4
Parikh Shamik J

Officer

Officer
45,887
0.90
US$41,147 		45,887 0.90 US$41,147
2026-05-18 2026-05-18 PrS Proposed sale
3.4
Sander Dale A.

Officer

Officer
45,887
0.90
US$41,147 		45,887 0.90 US$41,147
2026-05-18 2026-05-18 PrS Proposed sale
3.4
Sander Dale A.

Officer

Officer
45,887
0.90
US$41,147 		45,887 0.90 US$41,147
2025-08-20 2025-08-20 PrS Proposed sale
3.8
AYABUDGE LLC

Director

Non-Executive Director
591,685
1.58
US$936,654 		591,685 1.58 US$936,654
2025-08-20 2025-08-20 S Sale
3.2
Dougan Brady W
Non-Executive Director
591,685 -100.0%
1.58
US$934,862 		591,685 -100.0% 1.58 US$934,862
2025-08-20 2025-08-20 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
591,685 -100.0%
1.58
US$934,862 		591,685 -100.0% 1.58 US$934,862
2025-08-20 2025-08-19 S Sale
3.2
Dougan Brady W
Non-Executive Director
1,100,000 -65.0%
1.63
US$1,793,000 		1,100,000 -65.0% 1.63 US$1,793,000
2025-08-20 2025-08-19 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
1,100,000 -65.0%
1.63
US$1,793,000 		1,100,000 -65.0% 1.63 US$1,793,000
2025-08-19 2025-08-19 PrS Proposed sale
3.8
AYABUDGE LLC

Director

Non-Executive Director
1,100,000
1.63
US$1,790,244 		1,100,000 1.63 US$1,790,244
2025-08-20 2025-08-18 S Sale
3.2
Dougan Brady W
Non-Executive Director
549,360 -24.5%
1.83
US$1,005,329 		549,360 -24.5% 1.83 US$1,005,329
2025-08-20 2025-08-18 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
549,360 -24.5%
1.83
US$1,005,329 		549,360 -24.5% 1.83 US$1,005,329
2025-08-18 2025-08-18 PrS Proposed sale
3.8
AYABUDGE LLC

Director

Non-Executive Director
549,360
1.83
US$1,002,928 		549,360 1.83 US$1,002,928
2025-04-15 2025-04-14 B Purchase
2.0
Scheessele William John

Chief Commercial Officer

Officer
6,493 +41.8%
1.54
US$9,999 		6,493 +41.8% 1.54 US$9,999
2025-04-14 2025-04-10 B Purchase
3.4
Sander Dale A.

CFO and Chief Corp. Deve. Off.

Officer
20,000 +97.1%
1.53
US$30,600 		20,000 +97.1% 1.53 US$30,600
2025-04-14 2025-04-10 B Purchase
2.4
Parikh Shamik J

Chief Medical Officer

Officer
7,500 +inf%
1.55
US$11,625 		7,500 +inf% 1.55 US$11,625
2025-04-08 2025-04-08 B Purchase
2.5
Green Charles Bruce
Non-Executive Director
6,000 +250.0%
1.29
US$7,740 		6,000 +250.0% 1.29 US$7,740
2025-04-08 2025-04-08 B Purchase
3.1
Sebelius Kathleen
Non-Executive Director
50,000 +121.3%
1.32
US$66,000 		50,000 +121.3% 1.32 US$66,000
2025-04-08 2025-04-07 B Purchase
2.3
Constantino Michael T.
Non-Executive Director
16,000 +94.4%
1.26
US$20,160 		16,000 +94.4% 1.26 US$20,160
2024-12-04 2024-12-04 B Purchase
2.3
Constantino Michael T.
Non-Executive Director
4,600 +37.2%
4.39
US$20,181 		4,600 +37.2% 4.39 US$20,181
2024-11-20 2024-11-20 PrS Proposed sale
3.8
AYABUDGE LLC

Director

Non-Executive Director
261,369
4.40
US$1,149,218 		261,369 4.40 US$1,149,218
2024-11-20 2024-11-20 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
261,369 -13.1%
4.40
US$1,150,024 		261,369 -13.1% 4.40 US$1,150,024
2024-11-20 2024-11-20 S Sale
3.2
Dougan Brady W
Non-Executive Director
261,369 -13.1%
4.40
US$1,150,024 		261,369 -13.1% 4.40 US$1,150,024
2024-11-21 2024-11-19 B Purchase
3.2
Dougan Brady W
Non-Executive Director
1,797 +0.7%
4.44
US$7,979 		1,797 +0.7% 4.44 US$7,979
2024-11-21 2024-11-19 B Purchase
3.2
Niklason Laura E

President, CEO and Director

Executive Director
1,797 +0.7%
4.44
US$7,979 		1,797 +0.7% 4.44 US$7,979
2024-11-20 2024-11-19 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
427,459 -17.7%
4.34
US$1,855,172 		427,459 -17.7% 4.34 US$1,855,172
2024-11-20 2024-11-19 S Sale
3.2
Dougan Brady W
Non-Executive Director
427,459 -17.7%
4.34
US$1,855,172 		427,459 -17.7% 4.34 US$1,855,172
2024-11-19 2024-11-19 PrS Proposed sale
3.8
AYABUDGE LLC

Director

Non-Executive Director
427,459
4.34
US$1,854,067 		427,459 4.34 US$1,854,067
2024-11-20 2024-11-18 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
811,172 -25.1%
4.44
US$3,601,604 		811,172 -25.1% 4.44 US$3,601,604
2024-11-20 2024-11-18 S Sale
3.2
Dougan Brady W
Non-Executive Director
811,172 -25.1%
4.44
US$3,601,604 		811,172 -25.1% 4.44 US$3,601,604
2024-11-18 2024-11-18 PrS Proposed sale
3.8
AYABUDGE LLC

Director

Non-Executive Director
811,172
4.44
US$3,603,981 		811,172 4.44 US$3,603,981
2024-09-11 2024-09-10 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
288,674 -8.2%
5.23
US$1,509,765 		288,674 -8.2% 5.23 US$1,509,765
2024-09-11 2024-09-10 S Sale
3.2
Dougan Brady W
Non-Executive Director
288,674 -8.2%
5.23
US$1,509,765 		288,674 -8.2% 5.23 US$1,509,765
2024-09-11 2024-09-10 S Sale
3.1
Sebelius Kathleen
Non-Executive Director
1,548 -3.6%
5.39
US$8,344 		1,548 -3.6% 5.39 US$8,344
2024-09-11 2024-09-10 S Sale
3.1
Sebelius Kathleen
Non-Executive Director
3,634 -8.3%
5.41
US$19,660 		3,634 -8.3% 5.41 US$19,660
2024-09-10 2024-09-10 PrS Proposed sale
3.8
AYABUDGE LLC

Director

Non-Executive Director
288,674
5.23
US$1,510,584 		288,674 5.23 US$1,510,584
2024-09-10 2024-09-10 PrS Proposed sale
3.1
Sebelius Kathleen

Director

Non-Executive Director
5,182
5.41
US$28,012 		5,182 5.41 US$28,012
2024-09-11 2024-09-09 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
157,704 -4.3%
5.42
US$854,756 		157,704 -4.3% 5.42 US$854,756
2024-09-11 2024-09-09 S Sale
3.2
Dougan Brady W
Non-Executive Director
157,704 -4.3%
5.42
US$854,756 		157,704 -4.3% 5.42 US$854,756
2024-09-09 2024-09-09 PrS Proposed sale
3.8
AYABUDGE LLC

Director

Non-Executive Director
157,704
5.42
US$855,153 		157,704 5.42 US$855,153
2024-09-03 2024-08-29 B Purchase
3.2
Niklason Laura E

President, CEO and Director

Executive Director
1,222 +0.5%
6.55
US$7,998 		1,222 +0.5% 6.55 US$7,998
2024-09-03 2024-08-29 B Purchase
3.2
Dougan Brady W
Non-Executive Director
1,222 +0.5%
6.55
US$7,998 		1,222 +0.5% 6.55 US$7,998
2024-08-29 2024-08-29 PrS Proposed sale
3.8
AYABUDGE LLC

Director

Non-Executive Director
352,112
6.35
US$2,235,911 		352,112 6.35 US$2,235,911
2024-08-29 2024-08-29 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
352,112 -8.7%
6.35
US$2,235,911 		352,112 -8.7% 6.35 US$2,235,911
2024-08-29 2024-08-29 S Sale
3.2
Dougan Brady W
Non-Executive Director
352,112 -8.7%
6.35
US$2,235,911 		352,112 -8.7% 6.35 US$2,235,911
2024-08-29 2024-08-28 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
277,090 -6.4%
6.47
US$1,792,772 		277,090 -6.4% 6.47 US$1,792,772
2024-08-29 2024-08-28 S Sale
3.2
Dougan Brady W
Non-Executive Director
277,090 -6.4%
6.47
US$1,792,772 		277,090 -6.4% 6.47 US$1,792,772
2024-08-28 2024-08-28 PrS Proposed sale
3.8
Ayabudge LLC

Director

Non-Executive Director
277,090
6.47
US$1,792,772 		277,090 6.47 US$1,792,772
2024-08-29 2024-08-27 S Sale
3.4
Sander Dale A.

CFO and Chief Corp. Deve. Off.

Officer
39,389 -95.2%
6.68
US$263,119 		39,389 -95.2% 6.68 US$263,119
2024-08-29 2024-08-27 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
252,676 -5.5%
6.71
US$1,695,456 		252,676 -5.5% 6.71 US$1,695,456
2024-08-29 2024-08-27 S Sale
3.2
Dougan Brady W
Non-Executive Director
252,676 -5.5%
6.71
US$1,695,456 		252,676 -5.5% 6.71 US$1,695,456
2024-08-27 2024-08-27 PrS Proposed sale
3.8
Ayabudge LLC

Director

Non-Executive Director
252,676
6.71
US$1,696,341 		252,676 6.71 US$1,696,341
2024-08-27 2024-08-27 PrS Proposed sale
3.4
Sander Dale A.

Officer

Officer
39,389
6.68
US$263,311 		39,389 6.68 US$263,311
2024-08-15 2024-08-15 B Purchase
2.3
Constantino Michael T.
Non-Executive Director
3,100 +33.5%
6.29
US$19,494 		3,100 +33.5% 6.29 US$19,494
2024-06-13 2024-06-12 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
271,518 -5.6%
7.30
US$1,982,081 		271,518 -5.6% 7.30 US$1,982,081
2024-06-13 2024-06-12 S Sale
3.2
Dougan Brady W
Non-Executive Director
271,518 -5.6%
7.30
US$1,982,081 		271,518 -5.6% 7.30 US$1,982,081
2024-06-12 2024-06-12 PrS Proposed sale
3.8
Ayabudge LLC

Director

Non-Executive Director
250,000
7.20
US$1,800,000 		250,000 7.20 US$1,800,000
2024-06-13 2024-06-11 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
76,630 -1.6%
7.02
US$537,943 		76,630 -1.6% 7.02 US$537,943
2024-06-13 2024-06-11 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
282,000 -5.4%
7.09
US$2,000,000 		282,000 -5.4% 7.09 US$2,000,000
2024-06-13 2024-06-11 S Sale
3.2
Dougan Brady W
Non-Executive Director
76,630 -1.6%
7.02
US$537,943 		76,630 -1.6% 7.02 US$537,943
2024-06-13 2024-06-11 S Sale
3.2
Dougan Brady W
Non-Executive Director
282,000 -5.4%
7.09
US$2,000,000 		282,000 -5.4% 7.09 US$2,000,000
2024-06-04 2024-06-04 PrS Proposed sale
3.8
Ayabudge LLC

Director

Non-Executive Director
100,000
7.00
US$700,000 		100,000 7.00 US$700,000
2024-06-04 2024-06-04 B Purchase
3.2
Dougan Brady W
Non-Executive Director
2,362 +1.0%
6.35
US$14,999 		2,362 +1.0% 6.35 US$14,999
2024-06-04 2024-06-04 B Purchase
3.2
Niklason Laura E

President, CEO and Director

Executive Director
2,362 +1.0%
6.35
US$14,999 		2,362 +1.0% 6.35 US$14,999
2024-06-04 2024-06-04 S Sale
3.2
Dougan Brady W
Non-Executive Director
1,852 -0.0%
7.28
US$13,483 		1,852 -0.0% 7.28 US$13,483
2024-06-04 2024-06-04 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
1,852 -0.0%
7.28
US$13,483 		1,852 -0.0% 7.28 US$13,483
2024-06-04 2024-06-03 S Sale
3.2
Dougan Brady W
Non-Executive Director
190,214 -3.5%
7.42
US$1,411,388 		190,214 -3.5% 7.42 US$1,411,388
2024-06-04 2024-06-03 S Sale
3.2
Niklason Laura E

President, CEO and Director

Executive Director
190,214 -3.5%
7.42
US$1,411,388 		190,214 -3.5% 7.42 US$1,411,388
2024-06-03 2024-06-03 B Purchase
3.2
Niklason Laura E

President, CEO and Director

Executive Director
2,050 +0.9%
7.37
US$15,108 		2,050 +0.9% 7.37 US$15,108
2024-06-03 2024-06-03 B Purchase
3.2
Dougan Brady W
Non-Executive Director
2,050 +0.9%
7.37
US$15,108 		2,050 +0.9% 7.37 US$15,108
2024-06-04 2024-05-31 S Sale
3.2
Dougan Brady W
Non-Executive Director
93,213 -1.7%
8.93
US$832,392 		93,213 -1.7% 8.93 US$832,392
Explore more

More insider trading research around Humacyte Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America